Kindred Biosciences Announces First Quarter 2021 Financial Results

May 11, 2021

SAN FRANCISCO , May 11, 2021 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ: ...

Kindred Biosciences to Announce First Quarter 2021 Financial Results

May 3, 2021

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...

Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication

April 28, 2021

USDA approves the claim that the product is effective for the passive immunizatio...

Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study

April 20, 2021

- Engineered antibody demonstrates up to three-fold increase in half-life SAN FRA...

Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results

March 16, 2021

SAN FRANCISCO , March 16, 2021 /PRNewswire/ --  Kindred Biosciences, Inc. (NASDAQ...

Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results

March 8, 2021

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...

Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference

March 2, 2021

SAN FRANCISCO , March 2, 2021 /PRNewswire/ --  Kindred Biosciences, Inc.  (NASDAQ...

Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication

February 25, 2021

SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit

February 16, 2021

SAN FRANCISCO , Feb. 16, 2021 /PRNewswire/ --  Kindred Biosciences, Inc.  (NASDAQ...

Kindred Biosciences Announces Two New Appointments to Board of Directors

February 9, 2021

SAN FRANCISCO , Feb. 9, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...